Home · Health · Sep 1 archive

STAT+: 5 burning questions on Trump’s latest deals with drugmakers

Developing

Health Desk

Donald Trump Cabinet meeting 2017-03-13 01
Photo: Office of U.S. President / Wikimedia Commons (Public domain)

The Trump administration on Monday announced a second group of pharmaceutical companies had pledged to lower drug prices to levels comparable to those in other nations.

What's confirmed

What's still developing

Sources